| abstract |
Human splenin, human splenotritine, human splenopentine, acylated splenotritine, acylated splenopentine, acetylation, immunobiology, immune deficiencies, immune system, autoimmune reactions, bone carcinoma stem cells, AIDS, pharmacyn n n The invention relates to human splenin derivatives of the formula I and processes for their preparation. The new human splenin derivatives produced by customary synthetic methods of peptide chemistry have a high immunomodulating activity and high stability, and they show no neurotropic side effects. The compounds of the invention can be used to normalize the function of the immune system in primary and secondary immunodeficiencies and to stimulate stem cells of the bone marrow. |